PHC Holdings (6523) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 period of the fiscal year ending March 2026, the Company secured a slight increase in operating income, but net income declined substantially due to heavy financial expenses and tax burdens. Revenue was ¥2,692.5B (+0.9% YoY), while operating income was ¥171.1B (+0.5% YoY), both remaining nearly flat. In contrast, consolidated net income declined sharply to ¥5.3B (-93.0% YoY), while net income attributable to owners of the parent fell to ¥6.95B (-90.9% YoY). The primary factors were financial expenses of ¥148.3B, which absorbed approximately 87% of operating income, and income taxes and other taxes of ¥19.7B (effective tax rate: 78.7%) against profit before tax of ¥25.0B. Operating cash flow (OCF) was ¥272.3B and free cash flow was ¥214.3B, both remaining positive, indicating that the underlying business’s cash-generating capacity has not deteriorated to the same extent as earnings.

Factors Affecting Results

【Revenue】Revenue increased 0.9% YoY to ¥2,692.5B, with business scale remaining nearly flat. Progress against the full-year forecast of ¥3,631.0B was 74.2%, broadly in line with standard Q3 progress of approximately 75%.

【Profit and Loss】Operating income was ¥171.1B (+0.5% YoY), and the operating margin remained at 6.4%, broadly unchanged from the previous year. However, profit before tax was limited to ¥25.0B, as financial expenses of ¥148.3B absorbed most of operating income. In addition, income taxes and other taxes of ¥19.7B (effective tax rate: 78.7%) resulted in net income attributable to owners of the parent of ¥6.95B, a substantial decline from the ¥75.8B range in the previous year. In conclusion, the Company achieved higher revenue and operating income, but non-operating and tax factors resulted in a substantial decline in final earnings.

Key Financial Metrics

【Profitability】The operating margin of 6.4% remained broadly unchanged from 6.4% in the same period of the previous year, while the net margin attributable to owners of the parent declined substantially to 0.26% from 2.86% in the same period of the previous year. SG&A expenses accounted for most of gross profit, with a gross margin of 45.9% versus an SG&A ratio of 40.0%, limiting operating leverage. 【Cash Flow Quality】OCF of ¥272.3B significantly exceeded net income attributable to owners of the parent of ¥6.95B; however, this was the result of earnings being compressed by financial expenses and tax burdens and does not necessarily indicate high underlying earnings quality. An increase in inventories reduced OCF by ¥39.6B, while an increase in trade payables of ¥74.3B offset this impact. 【Investment Efficiency】ROE was extremely low at 0.3%, indicating substantial room for improvement in capital efficiency even with an equity ratio of 28.8% (improved from 26.6% in the previous year). Capital expenditures of ¥61.8B amounted to only approximately 30% of depreciation and amortization of ¥202.8B, indicating a restrained level of investment. 【Financial Soundness】Total assets were ¥5,526.7B and net assets were ¥1,586.1B. Goodwill of ¥2,203.2B reached 138.9% of net assets, indicating a structure in which a considerable portion of assets depends on maintaining the earnings power of acquired businesses.

Cash Flow Analysis

OCF was ¥272.3B (-1.6% YoY), remaining broadly at the previous year’s level. From subtotal operating cash flow of ¥371.9B, payments of income taxes and other taxes of ¥63.3B, interest payments of ¥38.9B, and lease payments of ¥44.2B were deducted, confirming the burden of financial and tax costs from a cash flow perspective as well. Investing cash flow was -¥57.9B, including capital expenditures of ¥61.8B. Financing cash flow was -¥225.6B, primarily reflecting repayments of long-term borrowings, and also included dividend payments of ¥51.3B. Free cash flow (OCF + investing cash flow) was positive at ¥214.3B, exceeding dividend payments; however, it should be noted that the fact that capital expenditures remained at approximately 30% of depreciation and amortization (¥202.8B) contributed to the increase in FCF.

Earnings Quality

The earnings structure for the period was characterized by operating income of ¥171.1B indicating recurring business earnings power, while substantial temporary and/or structural costs in the form of financial expenses of ¥148.3B arose in the conversion to profit before tax. Income taxes and other taxes of ¥19.7B represented an effective tax rate of 78.7% against profit before tax of ¥25.0B, with fluctuations in the tax burden amplifying volatility in net income. Comprehensive income was ¥221.2B, including ¥223.2B attributable to owners of the parent, substantially exceeding net income attributable to owners of the parent of ¥6.95B. This divergence was primarily due to other comprehensive income, particularly foreign currency translation adjustments. Accordingly, net income for the period may understate recurring earnings power and should be evaluated together with operating income and EBITDA.

Earnings Forecast and Guidance

Cumulative Q3 progress against the Company’s full-year forecast was 74.2% for revenue, 85.5% for operating income, and 34.8% for net income. Operating income was progressing at a pace above the standard progress rate of approximately 75%; against the full-year operating income forecast of ¥200.0B, achievement would require recording at least ¥28.9B in Q4. In contrast, net income progress was only 34.8% against the full-year forecast of ¥20.0B, substantially below standard progress. Recording approximately ¥13.1B in profit attributable to owners of the parent in Q4 will be necessary; however, if the high cumulative financial expenses and effective tax rate continue, achieving the forecast will present a considerable hurdle.

Shareholder Returns

The annual dividend forecast is ¥42.00, including the Q2 dividend of ¥21.00, and cumulative dividend payments total ¥51.3B. The payout ratio calculated using net income attributable to owners of the parent of ¥6.95B as the denominator is substantially above 100%, indicating that dividends cannot be covered by current-period earnings alone. However, OCF of ¥272.3B and free cash flow of ¥214.3B exceeded dividend payments of ¥51.3B by 5.3 times and 4.2 times, respectively, securing near-term cash payment capacity. No share repurchases were conducted, and shareholder returns consisted solely of dividends.

Risk Factors

1. High leverage and interest burden: Interest-bearing debt is primarily composed of short-term borrowings of ¥2,433.6B, while financial expenses of ¥148.3B absorbed approximately 87% of operating income of ¥171.1B. Resilience to rising interest rates and changes in refinancing terms is considered limited.

2. Concentration of assets in goodwill and intangible assets: Goodwill of ¥2,203.2B reached 138.9% of net assets of ¥1,586.1B and, together with intangible assets, accounts for a considerable portion of total assets. If the earnings plan for acquired businesses falls below expectations, impairment risk could materialize.

3. Working capital accumulation: Inventories were ¥589.7B, increasing from the previous year and reducing OCF by ¥39.6B. The turnover of trade receivables and inventories will require close monitoring as a factor affecting inventory valuation and liquidity when demand fluctuates.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s profitability is below the industry median, with net margin particularly underperforming due to the impact of financial expenses and tax burdens.

Growth and Capital Efficiency

Revenue growth also trailed the industry median, indicating a relatively moderate pace of top-line expansion.

※Source: Company analysis

Key Takeaways from the Results

1. While operating income increased 0.5% YoY and reached 85.5% of the full-year forecast, indicating the possibility of achieving the plan, net income declined 90.9% YoY and reached only 34.8% of the full-year forecast. The substantial divergence between operating performance and final earnings is a defining feature of these results.

2. Free cash flow of ¥214.3B exceeded dividend payments of ¥51.3B; however, it should be noted that capital expenditures remained at approximately 30% of depreciation and amortization, indicating that restrained investment supported FCF.

3. The asset composition, in which goodwill accounts for 138.9% of net assets, and the high financial expense burden, at approximately 87% of operating income, are factors that warrant attention in the future development of financial indicators.

Theoretical Share Price (Reference Value)

Sensitivity: ¥959–¥1,011 at ±1% for the cost of equity, and ¥976–¥990 at ±0.1 for ω.

Notes:

• Net income is substantially compressed relative to operating income due to tax burdens, acquisition-related expenses, and non-controlling interests (net income ÷ operating income: 10%). This value reflects that compression at face value, and if these factors are temporary, underlying earnings power may be higher.
• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Goodwill represents a high proportion of net assets, and the assumptions would change significantly if impairment were recognized.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).

（Valuation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices）

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

PHC Holdings’ FY2026 Q3 results show broadly stable revenue and operating profit but a severe deterioration in profit attributable to owners, driven primarily by sharply higher finance costs and an unusually high effective tax burden. Revenue increased 0.9% year on year to ¥269.3bn, while operating income rose only 0.5% to ¥17.1bn. The operating margin was therefore broadly flat at 6.4%, remaining below the 8% level generally associated with solid profitability. Gross profit declined 1.2% to ¥123.6bn despite revenue growth, and the gross margin compressed by approximately 98bp year on year to 45.9%. SG&A expense fell 0.6% to ¥107.7bn, which largely offset the gross-margin pressure and limited operating-margin compression to roughly 3bp. EBITDA was ¥37.4bn and the EBITDA margin was 13.9%, indicating that the underlying business continues to generate meaningful pre-financing cash earnings. However, finance costs surged to ¥14.8bn from ¥4.8bn in the prior-year period, consuming approximately 87% of operating income. Profit before tax consequently fell 80.0% to ¥2.5bn. Net income attributable to owners declined 90.9% to ¥0.7bn, equivalent to basic EPS of ¥5.50. The effective tax rate was 78.7%, further reducing already weak pre-tax earnings. Operating cash flow remained robust at ¥27.2bn and exceeded net income by 39.2x, reflecting non-cash charges and favorable operating cash generation rather than strong accounting earnings. Free cash flow was ¥21.4bn after ¥6.2bn of capital expenditures, providing near-term internal liquidity. Nevertheless, the balance sheet remains highly leveraged, with debt/equity of 2.48x, debt/EBITDA of 6.59x, and 98.7% of interest-bearing debt classified as short term. Goodwill of ¥220.3bn equals 138.9% of equity, leaving capital value highly dependent on the continued performance of acquired businesses. The full-year operating-income forecast of ¥20.0bn appears achievable based on the Q3 progress rate, but the forecast net-income progress rate is low at 34.8%, making the remaining-quarter recovery in financing and tax effects central to the earnings outlook.

Profitability Analysis

The reported annualized DuPont ROE is 0.6%, comprising a 0.3% net profit margin, 0.650x asset turnover, and 3.48x financial leverage. The weak ROE is principally a net-margin issue rather than an asset-utilization issue: high leverage does not translate into strong shareholder returns because financing costs and taxes absorb most operating earnings. The EBIT margin is 6.3%, while the net profit margin is only 0.3%, demonstrating a substantial deterioration below the operating line. The five-factor decomposition shows an interest burden of 0.146, meaning profit before tax retained only 14.6% of EBIT after net finance items. This was the largest adverse earnings driver, as finance costs increased 206.4% year on year to ¥14.8bn. The tax burden was also only 0.278, corresponding to a 78.7% effective tax rate and materially worsening the conversion of pre-tax profit into net income. Revenue growth of 0.9% was modest, while gross profit fell 1.2%, producing gross-margin compression of approximately 98bp to 45.9%. SG&A declined 0.6%, slightly faster than revenue, which provided limited operating leverage and held the operating-margin decline to around 3bp. EBITDA of ¥37.4bn and a 13.9% margin indicate that depreciation and amortization are substantial relative to EBIT, consistent with a business carrying significant acquired intangible assets. Under IFRS, goodwill is not amortized; consequently, the EBITDA measure does not require a JGAAP goodwill-amortization adjustment for cross-standard comparison. Annualized ROE remains far below typical cost-of-equity expectations, and the disclosed ROIC of 2.8% similarly indicates insufficient returns on the capital base. Profitability improvement will require a sustained recovery in gross margin and, more importantly, lower funding costs or lower gross debt.

Growth Assessment

Top-line momentum was limited, with Q3 cumulative revenue rising 0.9% year on year to ¥269.3bn. The decline in gross profit despite positive sales growth suggests that revenue expansion has not yet translated into improved unit economics. Operating income grew only 0.5%, broadly matching revenue growth and indicating little incremental operating leverage. The full-year revenue forecast is ¥363.1bn, and Q3 cumulative revenue represents 74.2% of that target, close to the standard 75% seasonal progress rate. The full-year operating-income forecast is ¥20.0bn, and Q3 cumulative operating income represents 85.5% of the target, 10.5 percentage points ahead of the standard 75% progress rate. This favorable operating-income progress provides a cushion against a softer fourth quarter, but it also implies that the full-year forecast embeds a materially lower Q4 operating-profit run rate than the first nine months. Net income attributable to owners has reached only 34.8% of the ¥2.0bn full-year forecast, substantially below normal Q3 progress. Achieving the full-year net-income target therefore requires a significant improvement in the fourth-quarter pre-tax and tax outcome. Operating cash flow of ¥27.2bn supports the resilience of the operating platform, although it should not be viewed as evidence that reported net profitability has normalized. Inventory increased by ¥7.3bn year on year and the disclosed annualized inventory days of 111 are elevated, increasing the importance of demand conversion and inventory discipline. Receivable days of 71 are also above the 60-day warning level, pointing to a relatively long cash-collection cycle. CapEx was only ¥6.2bn, or 0.30x depreciation and amortization, which supports short-term free cash flow but may constrain replacement investment and growth capacity if prolonged.

Financial Health

Financial health is the principal constraint in the current profile. The current ratio is approximately 0.52x, calculated from current assets of ¥189.2bn and current liabilities of approximately ¥361.1bn, and is below 1.0x; this is a clear liquidity warning. Current assets do not cover near-term obligations, creating a material maturity mismatch. Interest-bearing debt was ¥246.5bn, equivalent to debt/equity of 2.48x and debt/capital of 60.8%, both indicating aggressive debt financing. Debt/EBITDA of 6.59x is well above the 4.0x high-yield risk threshold. EBIT interest coverage was only approximately 1.15x based on operating income of ¥17.1bn and finance costs of ¥14.8bn, leaving little earnings headroom against further rate increases or operating volatility. The high interest burden is not typical of a conservatively financed medical-equipment and healthcare-solutions business and materially weakens financial flexibility. Short-term loans rose ¥209.1bn year on year to ¥243.4bn, while long-term loans fell ¥217.9bn to ¥3.1bn. This largely represents a debt maturity reclassification or refinancing structure rather than an equivalent increase in total borrowing, but it concentrates refinancing risk in the near term. Short-term debt represents 98.7% of interest-bearing debt, making continued access to bank and capital-market funding critical. Cash and cash equivalents of ¥44.9bn cover only about 18% of short-term loans, well below the 0.5x liquidity benchmark. Equity improved to ¥158.6bn from ¥141.2bn, aided principally by ¥21.6bn of other comprehensive income, including ¥25.0bn of foreign-currency translation gains. This OCI-led equity increase does not provide the same recurring capital accretion as retained earnings, which declined to a deficit of ¥0.8bn. Goodwill of ¥220.3bn is 39.9% of total assets and 138.9% of equity, so the balance sheet is highly exposed to any impairment of acquired business values. Intangible assets add another ¥76.4bn, bringing goodwill and intangible assets to 53.7% of total assets. The company should be assessed primarily on refinancing execution, interest-cost management, deleveraging capacity, and preservation of acquired-business cash flows.

Notable B/S Changes

Short-term loans: +¥209.1bn (+610.0%) to ¥243.4bn - debt has shifted overwhelmingly into current maturities, materially increasing refinancing and liquidity-management risk. Long-term loans: -¥217.9bn (-98.6%) to ¥3.1bn - largely offsets the increase in short-term loans and indicates a maturity reclassification or refinancing structure rather than a comparable rise in total debt, but creates substantial near-term maturity concentration. Retained earnings: -¥3.8bn (-127.3%) to -¥0.8bn - weak net income relative to dividends has eliminated the retained-earnings balance, limiting internally accumulated capital. Goodwill: +¥13.8bn (+6.7%) to ¥220.3bn - the absolute balance remains highly material at 138.9% of equity, requiring continued monitoring of impairment risk even though the year-on-year increase was not large. Equity attributable to owners: +¥17.6bn (+12.5%) to ¥159.3bn - improvement was supported substantially by other comprehensive income, particularly foreign-currency translation gains, rather than retained earnings.

Cash Flow Quality

Cash conversion was strong in the first nine months despite very weak reported net income. Operating cash flow was ¥27.2bn, compared with net income attributable to owners of ¥0.7bn, resulting in an OCF/net-income ratio of 39.18x. This ratio is not a conventional sign of superior recurring profitability; rather, it reflects the sharp compression in accounting earnings from finance costs and tax expense while operating cash earnings remained positive. EBITDA was ¥37.4bn, and OCF/EBITDA was 0.73x, below the 0.9x strong-conversion benchmark but above the 0.7x concern threshold. The accruals ratio was negative 4.8%, which is favorable and indicates that cash generation exceeded accrual-based earnings. Working-capital movements were net supportive: payables increased by ¥7.4bn and trade receivables declined by ¥4.2bn, partially offset by a ¥4.0bn inventory increase. The payable increase supported cash flow but should be monitored to determine whether it reflects normal purchasing volume and payment terms or temporary extension of supplier financing. Inventory accumulation consumed cash and is noteworthy given annualized inventory days of 111, which raises potential demand, obsolescence, and working-capital-release risk. Free cash flow was ¥21.4bn after capital expenditures of ¥6.2bn. CapEx represented only 0.30x depreciation and amortization, which boosts current free cash flow but constitutes an underinvestment warning if it persists. Cash flow also absorbed ¥3.9bn of interest paid and ¥4.4bn of lease payments, illustrating the recurring cash burden of the capital structure. Dividends paid totaled ¥5.1bn, leaving positive post-dividend free cash flow in the period. Operating cash generation is a near-term mitigant to liquidity risk, but it is insufficient on its own to resolve the concentration of short-term debt.

Dividend Sustainability

The indicated full-year dividend is ¥42.00 per share, comprising the ¥21.00 interim dividend and an implied ¥21.00 year-end dividend. Based on forecast EPS of ¥15.82, the forecast dividend payout ratio is approximately 265.5%, well above the 100% warning threshold. The reported Q3 cumulative payout ratio is 382.9% because cumulative net income attributable to owners was only ¥0.7bn. Free cash flow coverage was 8.05x on the reported calculation, so near-term cash generation can fund dividends despite the low accounting payout coverage. However, a cash-funded dividend is not automatically sustainable when debt/EBITDA is 6.59x, interest coverage is approximately 1.15x, and nearly all debt is short term. Dividends paid of ¥5.1bn also exceeded the ¥0.7bn cumulative profit attributable to owners, contributing to the deterioration in retained earnings. The payout assessment should therefore prioritize leverage reduction and refinancing requirements over free-cash-flow coverage in isolation. No share repurchase outflow was reported, so the analysis refers to the dividend payout ratio rather than a total return ratio. Continuation of the stated dividend requires delivery of the full-year earnings forecast, stable operating cash flow, and no material increase in funding costs. The dividend policy outlook is constrained by the need to rebuild retained earnings and preserve financial flexibility.

Risk Assessment

Business risks include Margin risk: gross margin declined by approximately 98bp to 45.9% despite revenue growth, demonstrating pressure in pricing, product mix, procurement costs, or manufacturing efficiency., Working-capital and demand risk: annualized receivable days of 71 and inventory days of 111 are above warning thresholds, increasing exposure to slower collections, inventory obsolescence, and future cash absorption., Acquisition-value risk: goodwill of ¥220.3bn equals 138.9% of equity and 5.89x EBITDA; under IFRS, goodwill is subject to impairment testing rather than amortization, so underperformance of acquired cash-generating units could result in a material impairment charge., Healthcare manufacturing risk: product quality, regulatory compliance, reimbursement conditions, supply-chain disruption, component availability, and foreign-exchange movements can affect volumes, prices, and manufacturing costs..

Financial risks include High leverage: debt/equity of 2.48x and debt/EBITDA of 6.59x indicate an aggressive capital structure and reduce tolerance for earnings volatility., Refinancing risk: ¥243.4bn of short-term loans account for 98.7% of interest-bearing debt, while cash covers only approximately 18% of short-term loans., Interest-rate risk: finance costs of ¥14.8bn consumed approximately 87% of operating income, producing EBIT interest coverage of only about 1.15x., Liquidity risk: the current ratio is approximately 0.52x, below 1.0x, indicating that current assets are insufficient to cover current liabilities without refinancing and operating cash inflows., Tax-risk volatility: the 78.7% effective tax rate materially weakened earnings conversion and could continue to cause large deviations between operating profit and net income..

Key concerns include Highest priority is refinancing execution because the debt maturity concentration, low cash-to-short-term-debt coverage, and weak interest coverage could have a high impact even if operating performance remains stable., The second priority is deleveraging through sustained EBITDA generation, disciplined capital allocation, and preservation of free cash flow., The third priority is protection of goodwill carrying value, given that a meaningful impairment would directly reduce already limited equity., The fourth priority is normalization of inventory and receivables, as elevated working-capital days may reverse recent cash-flow support., The full-year net-income forecast requires a substantial Q4 improvement despite Q3 cumulative progress of only 34.8%, leaving earnings delivery sensitive to financing costs and tax outcomes..

Investment Implications

Key takeaways include Operating performance was stable but not expanding: revenue grew 0.9% and operating income grew 0.5%, while gross margin compressed by approximately 98bp., EBITDA generation of ¥37.4bn and free cash flow of ¥21.4bn provide meaningful operating cash support., Net income attributable to owners fell 90.9% because finance costs rose sharply and the effective tax rate reached 78.7%., The balance sheet is leveraged and refinancing-dependent, with debt/EBITDA of 6.59x, debt/equity of 2.48x, and 98.7% short-term debt., Goodwill exceeds equity, making impairment avoidance and post-acquisition operating performance important determinants of equity value., The forecast operating-income target is substantially progressed at 85.5%, while forecast net-income progress is only 34.8%..

Metrics to watch include Short-term debt refinancing, weighted-average borrowing cost, and cash-to-short-term-debt coverage, Finance costs and EBIT interest coverage, Debt/EBITDA, debt/equity, and retained-earnings recovery, Gross margin, operating margin, and EBITDA margin, Inventory days, receivable days, and operating cash flow after working-capital movements, Goodwill impairment testing assumptions and acquired-business performance, Q4 progress toward the ¥2.0bn full-year net-income forecast, CapEx/depreciation, currently 0.30x, as an indicator of replacement-investment adequacy.

Regarding relative positioning, PHC Holdings currently presents a mixed profile: its EBITDA margin and operating cash generation are more resilient than its near-zero net margin suggests, but leverage, debt maturity concentration, weak interest coverage, elevated working-capital days, and goodwill concentration place it in a weaker financial-risk position than a conservatively financed healthcare-equipment peer. The key analytical distinction is between a viable cash-generating operating franchise and a capital structure that captures most of that operating profit through financing costs.